Terms: = Breast cancer AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1 AND Clinical Outcome
3 results:
1. gata1 promotes colorectal cancer cell proliferation, migration and invasion via activating AKT signaling pathway.
Yu J; Liu M; Liu H; Zhou L
Mol Cell Biochem; 2019 Jul; 457(1-2):191-199. PubMed ID: 31069596
[TBL] [Abstract] [Full Text] [Related]
2. The transcription factor gata1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer.
Zhang Y; Liu J; Lin J; Zhou L; Song Y; Wei B; Luo X; Chen Z; Chen Y; Xiong J; Xu X; Ding L; Ye Q
Oncotarget; 2016 Mar; 7(9):9859-75. PubMed ID: 26848522
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma.
Vo TN; Mekata E; Umeda T; Abe H; Kawai Y; Mori T; Kubota Y; Shiomi H; Naka S; Shimizu T; Murata S; Yamamoto H; Ishida M; Tani T
Breast Cancer; 2015 Mar; 22(2):117-28. PubMed ID: 23575921
[TBL] [Abstract] [Full Text] [Related]
